| Title |
Author |
Type |
Date |
Words |
| United States : $13 BILLION acquisition of Life Technologies is made by Thermo Fisher. |
|
|
Apr 15, 2013 |
196 |
| Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology. |
|
|
Mar 25, 2013 |
1515 |
| Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology. |
|
|
Mar 25, 2013 |
1520 |
| SHIRE PLC - Shire to Acquire SARcode Bioscience. |
|
|
Mar 25, 2013 |
1546 |
| SARcode Bioscience Announces Acquisition by Shire US Holdings Inc. |
|
|
Mar 25, 2013 |
882 |
| BGI-Shenzhen Completes Acquisition of Complete Genomics. |
|
|
Mar 18, 2013 |
878 |
| Shire Acquires Premacure AB. |
|
|
Mar 12, 2013 |
1477 |
| NeuroVive Acquires Highly Potent, Novel Cyclophilin Inhibitors From Biotica. |
|
|
Mar 11, 2013 |
794 |
| Pendrell buys 68% stake in biosciences innovator Provitro. |
|
Brief article |
Feb 26, 2013 |
236 |
| Illumina Completes Acquisition of Verinata Health. |
|
|
Feb 21, 2013 |
433 |
| Shire Acquires Lotus Tissue Repair, Inc. |
|
|
Jan 8, 2013 |
1308 |
| Elsevier Acquires Aureus Sciences, Provider of Databases and Information Tools for Pharmaceutical and Biotech Companies. |
|
|
Jan 8, 2013 |
782 |
| Shire Acquires Lotus Tissue Repair, Inc. |
|
|
Jan 8, 2013 |
1313 |
| Elsevier Acquires Aureus Sciences, Provider of Databases and Information Tools for Pharmaceutical and Biotech Companies. |
|
|
Jan 8, 2013 |
786 |
| Illumina Strengthens Leadership Position in Reproductive Health with Agreement to Acquire Verinata Health, Inc. |
|
|
Jan 7, 2013 |
1131 |
| Neogen acquires Scidera Genomics. |
|
|
Jan 2, 2013 |
538 |
| Retrophin Completes Reverse Merger With Desert Gateway, Inc. |
|
|
Dec 18, 2012 |
546 |
| Rockland Immunochemicals Acquires TrueBlot[R] Product Line. |
|
|
Dec 13, 2012 |
467 |
| Ventria Bioscience Acquires Meristem Therapeutics' Recombinant Lactoferrin Intellectual Property. |
|
|
Dec 3, 2012 |
360 |
| Nexira acquires Tournay Biotechnologies. |
|
|
Dec 1, 2012 |
128 |
| Evolva to acquire certain Fluxome assets. |
|
Brief article |
Dec 1, 2012 |
157 |
| Finland,India : TRIVITRON HEALTHCARE buys Finland s Ani Labsystems. |
|
|
Nov 29, 2012 |
151 |
| Spectrum Brands Holdings Acquires Majority Interest in Skin Care Technology Leader Shaser Bioscience, Inc. |
|
|
Nov 12, 2012 |
1786 |
| PerkinElmer Acquires China-based Infectious Disease Diagnostics Company. |
|
|
Nov 12, 2012 |
1332 |
| Biotechnology Merger and Acquisition Activity Continues Slump, According to New M&A Report from Irving Levin Associates. |
|
|
Nov 6, 2012 |
1046 |
| Canada : Warnex to Sell its Bioanalytical Services Division. |
|
|
Oct 26, 2012 |
483 |
| Canada : Abattis signs LOI to purchase Bio-Pharma license and equipment from Vertical Design Systems Ltd. |
|
|
Oct 19, 2012 |
240 |
| CytoDyn Announces Acquisition of Pro 140. |
|
|
Oct 17, 2012 |
1104 |
| Life Technologies Acquires Compendia Bioscience. |
|
|
Oct 8, 2012 |
1424 |
| BGI-Shenzhen Begins Tender Offer to Acquire Complete Genomics, inc. |
|
|
Sep 25, 2012 |
999 |
| Illumina Acquires BlueGnome, Leading Provider of Cytogenetics and In Vitro Fertilization Screening Solutions. |
|
|
Sep 19, 2012 |
618 |
| Rigrodsky & Long, P.A. Announces Investigation Of Complete Genomics, Inc. Buyout. |
|
|
Sep 18, 2012 |
354 |
| Rigrodsky & Long, P.A. Announces Investigation Of Complete Genomics, Inc. Buyout. |
|
|
Sep 17, 2012 |
354 |
| United Kingdom,United States : GLAXOSMITHKLINE acquires 15.2% stake in RESPONSE GENETICS. |
|
|
Sep 17, 2012 |
228 |
| United Kingdom : GSK to acquire five million shares in Response Genetics for US$1.10 per share in cash. |
|
|
Sep 14, 2012 |
133 |
| Spectrum Pharmaceuticals Completes Acquisition of Allos Therapeutics; Effective and Swift Integration Expected to Result In Significant Synergies. |
|
|
Sep 6, 2012 |
1678 |
| Cortex Pharmaceuticals and Pier Pharmaceuticals Consummate Merger. |
|
|
Aug 14, 2012 |
1519 |
| Upsher-Smith Completes Acquisition of Proximagen Group plc. |
|
|
Aug 14, 2012 |
860 |
| CytoDyn Announces Entry into Agreement with Progenics Pharmaceuticals, Inc. to Acquire PRO 140. |
|
|
Jul 30, 2012 |
1053 |
| Research and Markets: Harvard Bioscience Acquires AHN Biotechnologie to Complement its Molecular Laboratory Equipment Business. |
|
|
Jul 24, 2012 |
324 |
| Venture-Backed Life Science Companies Hit 7 Year Highs in Large Acquisitions. |
|
|
Jul 19, 2012 |
633 |
| GSK to acquire Human Genome Sciences for US$14.25 per share in cash. |
|
|
Jul 16, 2012 |
1711 |
| Theradiag Acquires Prestizia and Its Highly Innovative MicroRNA Technology Platform. |
|
|
Jun 27, 2012 |
560 |
| Affymetrix Completes Acquisition of eBioscience Holding Company, Inc. |
|
|
Jun 25, 2012 |
928 |
| Human Genome Sciences Announces July 16 as the Date for Submission of Definitive Acquisition Proposals. |
|
|
Jun 15, 2012 |
947 |
| REPEAT/Human Genome Sciences Announces July 16 as the Date for Submission of Definitive Acquisition Proposals. |
|
|
Jun 15, 2012 |
947 |
| Upsher-Smith Announces Transaction to Acquire UK-Based Proximagen. |
|
|
Jun 13, 2012 |
1577 |
| Israel,United States : OPKO HEALTH to purchase 45% stake in ISRAELI hepatitis B vaccine producer. |
|
|
Jun 8, 2012 |
171 |
| VWR International, LLC to Acquire basan Germany GmbH. |
|
|
May 31, 2012 |
320 |
| Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis. |
|
|
May 30, 2012 |
537 |
| Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis. |
|
|
May 30, 2012 |
530 |
| Affymetrix and eBioscience Amend Definitive Merger Agreement. |
|
|
May 4, 2012 |
1189 |
| Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd. |
|
|
May 3, 2012 |
646 |
| Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences. |
|
|
Apr 23, 2012 |
344 |
| Biotech Firm Spun Off from Children's Hospital Raises $7 Million. |
|
|
Mar 31, 2012 |
688 |
| RBCC Closes Deal with Game Changing Biotech Firm. |
|
|
Mar 15, 2012 |
546 |
| Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects. |
|
|
Mar 15, 2012 |
2533 |
| Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment. |
|
|
Mar 15, 2012 |
1234 |
| Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment. |
|
|
Mar 15, 2012 |
1233 |
| Valeant Pharmaceuticals Acquires a 19.9% Minority Equity Investment in Biotech Company in Brazil. |
|
|
Mar 12, 2012 |
589 |
| OriGene Technologies Announces the Acquisition of Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd, a Leading Chinese Pathology Reagent Company. |
|
|
Mar 12, 2012 |
241 |
| Discount Dental Materials, Inc. Acquires Cerebain Biotech Corp. |
|
|
Mar 2, 2012 |
518 |
| Biotech Firm Spun Off from Children's Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment. |
|
|
Mar 1, 2012 |
851 |
| ICON Acquires PriceSpective. |
|
|
Feb 28, 2012 |
876 |
| ADMA Biologics Completes Merger and Closes $17.5 Million Private Placement. |
|
|
Feb 14, 2012 |
887 |
| L'oreal completes Pacific Bioscience acquisition. |
|
|
Feb 1, 2012 |
353 |
| Amgen to Acquire Micromet. |
|
|
Jan 26, 2012 |
2696 |
| Amgen to Acquire Micromet. |
|
|
Jan 26, 2012 |
2701 |
| Courtagen Life Sciences Acquires Medicinal Genomics. |
|
|
Jan 18, 2012 |
523 |
| U.S. Federal Trade Commission Approves LabCorp's Acquisition of Orchid Cellmark. |
|
|
Dec 8, 2011 |
997 |
| InGen BioSciences Group Acquires Tetanos Quick Stick (TQS). |
|
|
Dec 7, 2011 |
1744 |
| Nu Skin acquires genomics firm. |
|
|
Dec 1, 2011 |
287 |
| UPS to Acquire Italian Pharma Logistics Company Pieffe. |
|
|
Dec 1, 2011 |
568 |
| Affymetrix to Acquire eBioscience. |
|
|
Nov 30, 2011 |
1285 |
| Synageva BioPharma Announces Completion of Merger with Trimeris. |
|
|
Nov 3, 2011 |
1072 |
| Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger. |
|
|
Oct 13, 2011 |
996 |
| Myriad Genetics has Option to Acquire Crescendo Bioscience. |
|
|
Sep 30, 2011 |
714 |
| Alkermes plc and Elan Corporation plc Announce Completion of Merger Between Alkermes, Inc. and Elan Drug Technologies. |
|
|
Sep 16, 2011 |
877 |
| Pathfinder, LLC and SyntheMed, Inc. Complete Merger. |
|
|
Sep 6, 2011 |
863 |
| EMD Millipore Strengthens Bioscience Business by Acquiring Amnis Corporation. |
|
|
Aug 30, 2011 |
626 |
| Dohmen Company Acquires St. Louis-Based Centric Health Resources, Inc. |
|
|
Aug 9, 2011 |
471 |
| Harvard Bioscience Acquires CMA Microdialysis' Preclinical Business. |
|
|
Aug 1, 2011 |
350 |
| SuperGen Completes Acquisition of Astex Therapeutics. |
|
|
Jul 20, 2011 |
760 |
| ICON Acquires Firecrest Clinical. |
|
|
Jul 14, 2011 |
612 |
| AE Biofuels Announces Acquisition of Industrial Biotechnology Company Zymetis. |
|
|
Jul 6, 2011 |
784 |
| Luminex Corporation to Acquire EraGen. |
|
|
Jul 1, 2011 |
763 |
| Staying positive: the Schiff-Ganeden acquisition proves that good deals can be made in a bad economy. |
Ismail, Adam |
|
Jul 1, 2011 |
756 |
| SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited. |
|
|
Jun 16, 2011 |
1027 |
| Synageva BioPharma and Trimeris Announce Merger Agreement. |
|
|
Jun 13, 2011 |
1841 |
| Can-Fite Signed an Agreement to Spin off Its Ophthalmology Activities to a US Based Public Company. |
|
|
Jun 6, 2011 |
531 |
| LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories. |
|
|
Jun 1, 2011 |
720 |
| Cannabis Science Negotiates Several Commercialization Deals To Make Its Anti-Cancer Cannabis Formulations Available To The Public. |
|
|
May 24, 2011 |
633 |
| Boston Equity Advisors Acts as Exclusive Agent and Advisor in Histogenics Acquisition of ProChon Biotech - Uniting Two Exciting Regenerative Medicine Product Programs. |
|
|
May 18, 2011 |
539 |
| Astellas and Maxygen Announce Completion of Acquisition of Perseid by Astellas. |
|
|
May 17, 2011 |
703 |
| Quest Diagnostics Successfully Completes Acquisition of Celera. |
|
|
May 17, 2011 |
399 |
| Histogenics Acquires ProChon Biotech. |
|
|
May 16, 2011 |
715 |
| Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger. |
|
|
May 11, 2011 |
877 |
| IntelliCell BioSciences Signs Merger Agreement with Media Exchange Group. |
|
|
Apr 27, 2011 |
479 |
| Quest Diagnostics Announces HSR Clearance for the Acquisition of Celera. |
|
|
Apr 13, 2011 |
814 |
| Sanofi-Aventis Completes Acquisition of Genzyme Corporation. |
|
|
Apr 8, 2011 |
952 |
| SuperGen and Astex Therapeutics Enter Definitive Merger Agreement. |
|
|
Apr 7, 2011 |
1586 |
| LabCorp Announces Definitive Agreement to Acquire Orchid Cellmark Inc. |
|
|
Apr 6, 2011 |
1547 |
| Medicomp, Inc. Announces Company Purchase From United Therapeutics. |
|
|
Apr 5, 2011 |
364 |
| Morphotek, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. |
|
|
Apr 4, 2011 |
1128 |
| Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective. |
|
|
Mar 29, 2011 |
839 |
| Milberg LLP Announces Investigation of Celera Corp. for Possible Breaches of Fiduciary Duty Relating to Quest Diagnostics Acquisition. |
|
|
Mar 21, 2011 |
237 |
| Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development. |
|
|
Mar 18, 2011 |
2214 |
| Kendall Law Group Investigates Celera Corporation Acquisition for Shareholders. |
|
|
Mar 18, 2011 |
264 |
| Murray, Frank & Sailer LLP Investigates Breaches Of Fiduciary Duty Regarding Acquisition Of Celera Corp. By Quest Diagnostics Inc. |
|
|
Mar 18, 2011 |
266 |
| Astellas Exercises Option to Purchase Maxygen's Interest in Perseid. |
|
|
Mar 17, 2011 |
1142 |
| Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs. |
|
|
Mar 8, 2011 |
2326 |
| Amgen Completes Acquisition of BioVex. |
|
|
Mar 4, 2011 |
1193 |
| EVOTEC ACQUIRES KINAXO EXPANDING DRUG DISCOVERY PLATFORM. |
|
|
Mar 1, 2011 |
679 |
| Monsanto Acquires Agricultural Technology Leader Divergence, Inc. |
|
|
Feb 22, 2011 |
993 |
| Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right. |
|
|
Feb 16, 2011 |
3006 |
| Sanofi could sweeten bid for Genzyme before next Wednesday: Report. |
|
|
Feb 4, 2011 |
170 |
| OPKO Health Acquires Biotechnology Company with Unique Platform Technology to Develop New Drugs. |
|
|
Feb 1, 2011 |
875 |
| Alexion Acquires Taligen Therapeutics and Creates Translational Medicine Group to Accelerate Development of Expanded Portfolio. |
|
|
Jan 31, 2011 |
775 |
| BioVex deal welcomed by company founder Sir Chris; BUYER WILL TAKE CANCER TREATMENT TO MARKET. |
|
|
Jan 28, 2011 |
534 |
| BioTime Acquires Assets of Cell Targeting, Inc. |
|
|
Jan 28, 2011 |
1204 |
| Illumina Acquires Epicentre Biotechnologies, Leading Provider of Nucleic Acid Sample Preparation Reagents and Specialty Enzymes. |
|
|
Jan 12, 2011 |
569 |
| Genzyme, Sanofi discuss higher buyout price: report. |
|
|
Jan 10, 2011 |
229 |
| Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement. |
|
|
Dec 22, 2010 |
1671 |
| Cypress Bioscience, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Ramius V&O Acquisition, LLC. |
|
|
Dec 20, 2010 |
400 |
| The Law Office of Abe Shainberg Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Cypress Bioscience, Inc. in Connection with the Sale of Company to Ramius V & O Acquisition, LLC- CYPB. |
|
|
Dec 17, 2010 |
240 |
| Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Cypress Bioscience, Inc., in Connection with the Proposed Acquisition of the Company by Ramius V&O Acquisition LLC. |
|
|
Dec 17, 2010 |
292 |
| Cypress Bioscience Agrees To Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share in Cash. |
|
|
Dec 15, 2010 |
1755 |
| The Law Firm of Weiss & Lurie Investigates the Acquisition of Cypress Bioscience, Inc. by Ramius V&O Acquisition LLC and Royalty Pharma. |
|
|
Dec 15, 2010 |
335 |
| Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share. |
|
|
Dec 10, 2010 |
1957 |
| Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell. |
|
|
Dec 8, 2010 |
6284 |
| LabCorp Successfully Completes Acquisition of Genzyme Genetics. |
|
|
Dec 1, 2010 |
434 |
| Amgen Eyeing Possible bid for Swiss drugmaker Actelion. Amgen Inc. |
|
|
Nov 22, 2010 |
423 |
| LabCorp's Acquisition of Genzyme Genetics Clears Antitrust Review. |
|
|
Nov 18, 2010 |
537 |
| Human Genome may be takeover Target. Human Genome Sciences Inc. |
|
|
Nov 15, 2010 |
360 |
| Sanofi Posts Strong Profit; Defends Genzyme Bid. Sanofi-Aventis SA. |
|
Financial report |
Nov 1, 2010 |
211 |
| Genzyme says Sanofi should boost Buyout bid to $89 a share. Genzyme Corp. |
|
|
Oct 25, 2010 |
340 |
| Galapagos raises EUR 28.7m for acquisitions. |
|
|
Oct 20, 2010 |
115 |
| Genzyme says MS success helps justify higher Sanofi buyout offer. Genzyme corp. |
|
|
Oct 18, 2010 |
329 |
| Cell Biosciences to Acquire Convergent Bioscience. |
|
|
Oct 13, 2010 |
532 |
| Cell Biosciences to Acquire Convergent Bioscience. |
|
|
Oct 13, 2010 |
537 |
| Sanofi Begins Hostile Bid for Genzyme. |
|
|
Oct 11, 2010 |
392 |
| Alltech. |
|
Brief article |
Oct 1, 2010 |
142 |
| Triple i Acquires Phoenix Marketing Group, LLC. |
|
|
Sep 20, 2010 |
485 |
| Genzyme unit sale may push Sanofi to raise bid. Genzyme Corp. |
|
|
Sep 20, 2010 |
330 |
| LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics. |
|
|
Sep 13, 2010 |
754 |
| Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville. |
|
|
Aug 18, 2010 |
521 |
| BioMarin Acquires ZyStor Therapeutics, Inc. |
|
|
Aug 17, 2010 |
1788 |
| Genzyme's plant problems factor into Sanofi bid. Sanofi-Aventis SA. |
|
|
Aug 16, 2010 |
480 |
| OriGene Technologies Acquires Blue Heron Biotechnology, a Leading U.S.-based Gene Synthesis Company. |
|
|
Aug 12, 2010 |
363 |
| CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc. |
|
|
Aug 3, 2010 |
352 |
| United States : Sanofi reportedly planning takeover bid for Genzyme. |
|
|
Jul 27, 2010 |
327 |
| Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc. |
|
|
Jul 27, 2010 |
864 |
| Sanofi-Aventis rumored to bid for Genzyme. Sanofi-Aventis SA. |
|
|
Jul 26, 2010 |
280 |
| Sanofi approaches Genzyme for acquisition. |
|
|
Jul 25, 2010 |
296 |
| United States : MDRNA receives shareholders approval to acquire Cequent Pharmaceuticals. |
|
|
Jul 25, 2010 |
221 |
| Kendall Law Group Investigates Cypress Bioscience, Inc. Acquisition for Shareholders. |
|
|
Jul 20, 2010 |
236 |
| Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Cypress Bioscience, Inc. - CYPB. |
|
|
Jul 19, 2010 |
300 |
| Tripp Levy PLLC Investigates Buyout of Cypress Bioscience by Ramius. |
|
|
Jul 19, 2010 |
369 |
| China Kangtai Cactus Biotech Announces Acquisition of Tobacco Manufacturer. |
|
|
Jul 6, 2010 |
673 |
| Celgene to buy Abraxis BioScience. |
|
|
Jul 5, 2010 |
401 |
| Sanofi said to plan major US acquisition. Sanofi-Aventis SA. |
|
|
Jul 5, 2010 |
302 |
| Sanofi looking at US deals. |
|
|
Jul 4, 2010 |
256 |
| Lilly to Acquire Alnara Pharmaceuticals. |
|
|
Jul 2, 2010 |
1134 |
| LILLY (ELI) & COMPANY - Statement re Lilly to Acquire Alnara Pharmaceuticals. |
|
|
Jul 2, 2010 |
1115 |
| Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition. |
|
|
Jul 2, 2010 |
450 |
| Sanofi-aventis to Acquire TargeGen, Inc. |
|
|
Jun 30, 2010 |
437 |
| MP Biomedicals Acquires New Zealand Protein Biologics Company. |
|
|
Jun 14, 2010 |
309 |
| Unlocking the code for federal research grants: federal grants targeted for small business help fund Austin biotech company's groundbreaking research. |
Calnan, Christopher |
Company overview |
Jun 1, 2010 |
784 |
| TiGenix becomes easy takeover target on recent stock fall - CEO. |
|
|
May 25, 2010 |
257 |
| ICON Acquires Timaq Medical Imaging inc. |
|
|
May 24, 2010 |
406 |
| Unlocking the code for federal research grants; federal grants targeted for small business help fund Austin biotech company's groundbreaking research. |
Calnan, Christopher |
Company overview |
May 21, 2010 |
784 |
| Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc. |
|
|
May 16, 2010 |
1451 |
| CCS Cell Culture Service GmbH Acquires the MaxCyte[R] STX[TM] Scalable Transfection System for Cell Line Development. |
|
|
May 11, 2010 |
422 |
| BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition. |
|
|
May 3, 2010 |
1772 |
| Primex: making a big splash in the marine products market. |
|
|
May 1, 2010 |
646 |
| BioTime, Inc. Announces Agreement to Acquire ES Cell International. |
|
|
Apr 29, 2010 |
962 |
| Mesa Labs Acquires SGM Biotech, Inc. |
|
|
Apr 27, 2010 |
806 |
| Abbott Completes Acquisition of Facet Biotech. |
|
|
Apr 21, 2010 |
466 |
| Abraxis Bioscience Inc. |
|
Brief article |
Apr 19, 2010 |
184 |
| Silence Therapeutics Executes Strategic Plan to Optimize and Integrate Technologies and Assets From Intradigm Merger. |
|
|
Apr 13, 2010 |
680 |
| SILENCE THERAPEUTICS PLC - Silence(AIM:SLN) Integrates Assets from Intradigm Merger. |
|
|
Apr 13, 2010 |
750 |
| Kendall Law Group Investigates Facet Biotech Corporation Merger for Shareholders. |
|
|
Mar 10, 2010 |
216 |
| Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech; - Provides Promising Biologic Intended to Treat Multiple Sclerosis and Compounds that Complement Abbott's Existing Diverse Oncology Program. |
|
|
Mar 9, 2010 |
1661 |
| Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech. |
|
|
Mar 9, 2010 |
1692 |
| German Merck has more takeover ideas. |
|
|
Mar 7, 2010 |
318 |
| AltraVax, Inc. Acquires Revolutionary Technology Platform for Vaccine Development. |
|
|
Feb 18, 2010 |
457 |
| Galapagos to buy Argenta Discovery's service division for EUR 16.5m. |
|
|
Feb 2, 2010 |
150 |
| Life Technologies Completes Divestiture of Mass Spectrometry Business. |
|
|
Feb 1, 2010 |
439 |
| Ligand Completes Acquisition of Metabasis. |
|
|
Jan 28, 2010 |
934 |
| Icelandic Gene Pioneer Decode back. |
|
Brief article |
Jan 25, 2010 |
262 |
| Life Technologies Signs Definitive Agreement to Acquire AcroMetrix. |
|
|
Jan 12, 2010 |
742 |
| BGI Purchases 128 Illumina HiSeq[TM] 2000 Sequencing Systems. |
|
|
Jan 12, 2010 |
636 |
| CombinatoRx and Neuromed Close Merger. |
|
|
Dec 21, 2009 |
1020 |
| Biogen's bid for facet fails to win investor support. |
|
|
Dec 21, 2009 |
346 |
| Merck buys British maker of biotech medicines. |
|
Brief article |
Dec 21, 2009 |
272 |
| Galapagos acquisition not ruled out - CEO. |
|
|
Dec 16, 2009 |
137 |
| Life Technologies Completes Acquisition of BioTrove. |
|
|
Dec 15, 2009 |
419 |
| Asterand Announces Agreement to Acquire BioSeek. |
|
|
Nov 18, 2009 |
1303 |
| Trimeris Announces Extension of Arigene Tender Offer and Amendment of Merger Agreement. |
|
|
Nov 17, 2009 |
529 |
| Belgian TiGenix to buy UK Orthomimetics. |
|
|
Nov 16, 2009 |
106 |
| Danisco A/S signs Agreement to acquire French Biotechnology Company Sorbial. |
|
|
Nov 11, 2009 |
269 |
| Life Technologies Signs Definitive Agreement to Acquire BioTrove. |
|
|
Nov 10, 2009 |
893 |
| Naturex and Natraceutical Group formalize merger. |
|
Brief article |
Nov 1, 2009 |
105 |
| Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon. |
|
|
Oct 23, 2009 |
830 |
| Arigene Co., Ltd. Commences Tender Offer to Acquire All Outstanding Shares of Trimeris, Inc. Stock for $3.60 Per Share in Cash. |
|
|
Oct 19, 2009 |
1049 |
| Johnson & Johnson Inc. |
|
Brief article |
Oct 5, 2009 |
277 |
| Arigene Co., Ltd. to Acquire Trimeris, Inc. |
|
|
Oct 2, 2009 |
1048 |
| CBR Pharma Insights: New Report - Pharmaceutical Mergers and Acquisitions - M&A in the Biopharmaceutical Industry and the Impact on Innovation (CBRSV006). |
|
|
Sep 30, 2009 |
343 |
| Daily Outlook - Sept 28. |
|
|
Sep 28, 2009 |
425 |
| Alcon to buy Swiss Biotech firm for up to $589 million. |
|
Brief article |
Sep 21, 2009 |
233 |
| Facet Biotech rises after board rejects Biogen takeover bid. |
|
Brief article |
Sep 14, 2009 |
311 |
| Roche Holding AG. |
|
Brief article |
Sep 14, 2009 |
230 |
| Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG. |
|
|
Sep 13, 2009 |
866 |
| IPO sector: Talecris Biotherapeutics Holdings Corp. |
|
Brief article |
Aug 3, 2009 |
241 |
| SENESCO SIGNS PACT FOR UP TO $1.0 MILLION IN FINANCING. |
|
|
Aug 1, 2009 |
523 |
| J&J second-quarter profit tops estimates. |
|
Financial report |
Jul 20, 2009 |
314 |
| Biotech drug copies could be held up 13 years under Senate plan. |
|
|
Jul 13, 2009 |
366 |
| J&J buys $1 billion Elan stake; gains Alzheimer's R&D. |
|
|
Jul 6, 2009 |
399 |
| Daily Wrap Up for July 2 - Industries. |
|
Brief article |
Jul 2, 2009 |
234 |
| Mid-day Minute news - July 2. |
|
|
Jul 2, 2009 |
483 |
| CombinatoRx and Neuromed Sign Merger Agreement. |
|
|
Jul 1, 2009 |
2205 |
| Bio-Bridge Science Subsidiary Acquires a Raw Bovine Serum Collection Center in Beian City, Heilongjiang Province, China. |
|
|
Jul 1, 2009 |
396 |
| KAI Pharmaceuticals Acquires Patents from Progen, Broadening KAI's Intellectual Property Estate Covering Peptide-Based Therapies. |
|
|
Jun 30, 2009 |
328 |
| UBS says Bristol-Myers not in talks for Elan Stake. |
|
Brief article |
Jun 8, 2009 |
167 |
| The US Federal Trade Commission is opposed to Australian biotech firm CSL Ltd's planned purchase of smaller US rival Talecris Biotherapeutics Holdings Corp (Research Triangle Park NC), CSL said last week. |
|
Brief article |
Jun 1, 2009 |
172 |
| Genentech: the king is dead. |
Lampard, Graham |
Brief article |
May 1, 2009 |
306 |
| Roche Acquired drug Avastin fails cancer study, shares fall. |
|
Brief article |
Apr 22, 2009 |
168 |
| URCH Publishing (London), a publisher of market intelligence reports covering the global pharmaceutical and healthcare industry, has acquired Spectra Intelligence (London), a privately owned publisher of specialized and syndicated pharmaceutical market research. |
|
|
Apr 16, 2009 |
106 |
| Roche reins new Management. |
|
Brief article |
Apr 15, 2009 |
172 |
| An experimental cancer drug made by Japan's Takeda Pharmaceutical Co showed signs of slowing tumors growth in mice and has advanced to early human trials, company researchers said. |
|
Brief article |
Apr 13, 2009 |
291 |
| Roche Holding AG had its long-term debt rating cut by Moody's Investors Service because of the increased borrowings to fund the Swiss company's $46.8 billion acquisition of the rest of Genentech Inc. (S. San Francisco CA). |
|
Brief article |
Mar 30, 2009 |
284 |
| Navigenics Acquires Clinical Testing Facility. |
|
|
Mar 19, 2009 |
371 |
| Roche wins Genentech with raised $95-per-share offer. |
|
|
Mar 16, 2009 |
487 |
| Will Roche be able to keep top Genentech talent? |
|
|
Mar 13, 2009 |
534 |
| Lifeline Biotechnologies Acquires MastaScope[TM] and OvaScope[TM] Technology. |
|
|
Mar 11, 2009 |
438 |
| Roche raises offer to buy Genentech to $93 a share. |
|
Brief article |
Mar 9, 2009 |
298 |
| Genentech escalates battle against Roche hostile bid. |
|
Brief article |
Mar 2, 2009 |
252 |
| Invitrogen + Applied Biosystems = LIFE. |
|
Brief article |
Mar 1, 2009 |
125 |
| Roche to raise $16 billion in bond sale for Genentech takeover. |
|
Brief article |
Feb 23, 2009 |
261 |
| GPC Biotech and Agennix Announce Proposed Merger. |
|
|
Feb 18, 2009 |
2195 |
| Roche launches Genentech offer, plans board change. |
|
Brief article |
Feb 16, 2009 |
308 |
| Roche goes hostile, cuts Genentech bid to $42 billion. |
|
Brief article |
Feb 9, 2009 |
326 |
| Takeda Pharmaceutical Ltd, Japan's largest drugmaker, said third-quarter operating profit rose nearly 10%, helped by the acquisition of US biotech firm Millennium Pharmaceutical and the absorption of part of a former US joint venture. |
|
Brief article |
Feb 9, 2009 |
238 |
| Sequenom Terminates Exchange Offer to Acquire EXACT Sciences. |
|
|
Jan 28, 2009 |
466 |
| Sequenom Commences Exchange Offer to Acquire EXACT Sciences. |
|
|
Jan 27, 2009 |
991 |
| Johnson & Johnson Inc. |
|
Brief article |
Jan 26, 2009 |
174 |
| Danish pharmaceutical group Lundbeck A/S is interested in acquiring Irish biotechnology firm Elan Corp Plc, the Sunday Independent newspaper reported, without citing sources. |
|
Brief article |
Jan 26, 2009 |
191 |
| NitroMed Special Meeting of Stockholders Further Adjourned Today to Consider Higher Bid From Deerfield Management. |
|
|
Jan 20, 2009 |
1356 |
| Swiss drugmaker Roche AG reaffirmed its dividend policy last week, dismissing talk it might sacrifice payouts to help fund a sweetened offer for the remainder of US biotech giant Genentech Inc (South San Francisco). |
|
Brief article |
Jan 19, 2009 |
168 |
| Sequenom to Commence Exchange Offer to Acquire EXACT Sciences. |
|
|
Jan 14, 2009 |
1060 |
| NitroMed Special Meeting of Stockholders Adjourned Today to Consider Higher Bid From Deerfield Management. |
|
|
Jan 14, 2009 |
1337 |
| Company rejects a $41M bid; San Diego firm pursues EXACT. |
|
|
Jan 13, 2009 |
505 |
| NitroMed Receives Revised Unsolicited Acquisition Proposal from Deerfield Management. |
|
|
Jan 12, 2009 |
1269 |
| EXACT Sciences Board of Directors Rejects Acquisition Proposal from Sequenom, Inc. |
|
|
Jan 12, 2009 |
701 |
| Elan Corp. |
|
Brief article |
Jan 12, 2009 |
130 |
| Wyeth targets Crucell vaccines. |
|
Brief article |
Jan 12, 2009 |
285 |
| Sequenom Proposes to Acquire EXACT Sciences for $1.50 Per Share or Approximately $41 Million. |
|
|
Jan 9, 2009 |
1469 |
| Avexa and Progen Merger Update. |
|
|
Jan 5, 2009 |
690 |
| VALEANT TO ACQUIRE DOW PHARMACEUTICAL SCIENCES FOR $285 MIL. |
|
|
Jan 1, 2009 |
671 |
| Chr. Hansen acquires Urex Biotech Inc. |
|
|
Jan 1, 2009 |
327 |
| Wyeth Inc. |
|
Brief article |
Dec 22, 2008 |
181 |
| Swiss drugmaker Roche Holding AG is still committed to its bid to buy out Genentech Inc (South San Francisco), its chief executive was quoted as saying. |
|
Brief article |
Dec 15, 2008 |
137 |
| Affymetrix Completes Acquisition of Panomics. |
|
|
Dec 8, 2008 |
818 |
| Alnylam Strengthens Intellectual Property Estate through Acquisition of Nucleonics Patent Assets. |
|
|
Dec 8, 2008 |
1657 |
| Johnson & Johnson to buy Omrix for $438 million. |
|
Brief article |
Dec 1, 2008 |
205 |
| Invitrogen & Applied Biosystems Merge to Form Life Technologies; Fitch Rtd 'BBB-'. |
|
|
Nov 24, 2008 |
367 |
| Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc. |
|
|
Nov 19, 2008 |
1151 |
| Mintz Levin Represents Genelabs Technologies in $57M Deal with GlaxoSmithKline. |
|
|
Nov 18, 2008 |
334 |
| NitroMed and Archemix Announce Merger Agreement. |
|
|
Nov 18, 2008 |
2677 |
| Affymetrix to Acquire Panomics. |
|
|
Nov 11, 2008 |
944 |
| Invitrogen Provides Update on Merger with Applied Biosystems. |
|
|
Nov 4, 2008 |
788 |
| Merger kept 'the best of both'; Merck KGaA of Germany acquired Swiss Serono in January 2007 and set managers to the task of creating a powerhouse in Merck Serono International S.A. |
Davis, Nancy M. |
|
Nov 1, 2008 |
1325 |
| Sartorius Stedim Biotech acquires Wave Biotech. |
|
Brief article |
Nov 1, 2008 |
208 |
| Sartorius Stedim Biotech Acquires Wave Biotech AG. |
|
|
Oct 31, 2008 |
720 |
| GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C. |
|
|
Oct 30, 2008 |
994 |
| Applied Biosystems Stockholders Approve Merger with Invitrogen. |
|
|
Oct 28, 2008 |
1096 |
| Bristol-Myers has "long list" of deal targets. |
|
Brief article |
Oct 27, 2008 |
256 |
| IDEX Corporation Acquires Semrock. |
|
|
Oct 20, 2008 |
363 |
| Invitrogen Files Merger Notification With European Commission. |
|
|
Oct 7, 2008 |
603 |
| Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger. |
|
|
Oct 6, 2008 |
902 |
| Critical Therapeutics, Inc. Announces Effectiveness of Registration Statement for the Proposed Merger with Cornerstone BioPharma Holdings, Inc. |
|
|
Oct 3, 2008 |
1079 |
| Excalibur - 'Transforming' Biotech Deals can Still be Achieved. |
|
Company overview |
Oct 1, 2008 |
410 |
| Cornerstone Completes Merger with Critical Therapeutics. |
|
|
Oct 1, 2008 |
529 |
| Sequenom buys clinical diagnostic lab. |
|
Brief article |
Sep 30, 2008 |
212 |
| Small biotechnology companies with serious cash raised via initial public offerings, but also with failed or floundering products, are in hot demand as partners for companies that are unable to raise money in the capital markets. |
|
Brief article |
Sep 29, 2008 |
106 |
| Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition. |
|
|
Sep 26, 2008 |
719 |
| Aspen Racing Stables, Inc. Completes Reverse Merger Transaction with Kun Run Biotechnology Ltd. |
|
|
Sep 25, 2008 |
142 |
| pounds 218m deal creates UK biotech giant; 'This is right way ahead'. |
|
|
Sep 19, 2008 |
401 |
| Sequenom Acquires Exclusive License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property. |
|
|
Sep 16, 2008 |
974 |
| Invitrogen Provides Update on Regulatory Review and Financing for the Applied Biosystems Acquisition. |
|
|
Sep 16, 2008 |
705 |
| Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems. |
|
|
Sep 3, 2008 |
808 |
| Applied bio and Invitrogen set date for shareholder votes. |
|
Brief article |
Aug 31, 2008 |
235 |
| Applied Biosystems Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger With Invitrogen Corporation. |
|
|
Aug 25, 2008 |
684 |
| Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems. |
|
|
Aug 25, 2008 |
595 |
| Takeda Pharmaceutical Co, Asia a [euro] [TM]s largest drugmaker, raised its fullyear profit forecast by 25% after lowering writedowns on its $9 billion acquisition of Millennium Pharmaceuticals Inc (Cambridge MA). |
|
Brief article |
Aug 4, 2008 |
229 |
| Biotech Red Hot in July as Potential Blockbuster M&A Deals Awake Investors from Their Summer Slumber, Burrill Reports. |
|
|
Aug 1, 2008 |
800 |
| Affymetrix acquires bead-based technology. |
|
Brief article |
Jul 31, 2008 |
185 |
| Bio-Bridge Science Completes Acquisition of Xinheng Baide Biotechnology Co. Ltd. |
|
|
Jul 31, 2008 |
420 |
| ThromboGenics Announces Private Investors Acquire 8% Stake in the Company. |
|
|
Jul 30, 2008 |
575 |
| Roche makes bid for remaining shares of Genentech. |
|
Brief article |
Jul 28, 2008 |
309 |
